首页> 外国专利> DERIVATED DTPA COMPLEXES, PHARMACEUTICALS CONTAINING THESE COMPOUNDS, THEIR USE AS NMR AND RADIOGRAPHIC CONTRASTING AGENTS AND PROCESS FOR PRODUCING THE SAME

DERIVATED DTPA COMPLEXES, PHARMACEUTICALS CONTAINING THESE COMPOUNDS, THEIR USE AS NMR AND RADIOGRAPHIC CONTRASTING AGENTS AND PROCESS FOR PRODUCING THE SAME

机译:衍生的DTPA复合物,包含这些化合物的药物,用作NMR和射线照相造影剂的方法及其制备方法

摘要

Complex compounds and their salts consist of at least one metal ion and a complexing agent having general formula (I), in which Z1 and Z2 represent independently from each other a hydrogen atom, the residue -(CH2)m-(C6H4)q-(O)k- (CH2)n-(C6H4)l-(O)r-R, or the residue -(CH2)m-(C6H10)q-(O)k- (CH2)n-(C6H10)l-(O)r-R, in which m and n are the numbers 0-5, q, k, l and r are the numbers 0 or 1 and s is the number 1 or 2; R stands for a hydrogen atom, an if required OR1-substituted, straight-chain or branched-chain C1-C6-alkyl residue or a CH2-COOR1 group, in which R1 stands for a hydrogen atom, a C1-C6-alkyl residue or a benzyl group, with the proviso that one of the substituents Z1 or Z2 stands for a hydrogen atom and the other does not, and that a direct oxygen-oxygen bond is not allowed. Also disclosed is their use for producing radiotherapy agents and NMR and radiographic diagnosing agents, in particular for contrasting the hepatobiliary system. A process for producing these compounds and agents is further disclosed.
机译:配位化合物及其盐由至少一种金属离子和具有通式(I)的配位剂组成,其中Z 1和Z 2彼此独立地表示氢原子,-(CH 2)m-(C 6 H 4)q-残基(O)k-(CH2)n-(C6H4)1-(O)rR或残基-(CH2)m-(C6H10)q-(O)k-(CH2)n-(C6H10)1-( O)rR,其中m和n是数字0-5,q,k,l和r是数字0或1,s是数字1或2; R代表氢原子,如果需要的话,OR1取代的直链或支链的C1-C6-烷基残基或CH2-COOR1基团,其中R1代表氢原子,C1-C6-烷基残基或苄基,条件是取代基Z1或Z2之一代表氢原子,另一个不代表氢原子,并且不允许直接的氧-氧键。还公开了它们在生产放射治疗剂和NMR以及放射照相诊断剂中的用途,特别是在对比肝胆系统中的用途。还公开了生产这些化合物和试剂的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号